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Abstract
Chronic kidney disease (CKD) is an important cause of morbidityBackground: 
and mortality globally. However, there are limited data on the prevalence of
impaired kidney function in sub-Saharan Africa. We aimed to determine the
prevalence of CKD and associated factors in a rural Ugandan population.
We undertook a study of a representative sample of the GeneralMethods:  
Population Cohort in South-western Uganda. We systematically collected data
on cardiovascular disease risk factors, anthropometric measurements and
blood tests for haemoglobin, HIV, HbA1c, Hepatitis B and C and serum
creatinine.  The estimated glomerular filtration rate (eGFR) was calculated
using the CKD-Epi formula, without the race component of the equation.
A total of 5,979/6,397 (93.5%) participants had valid creatinineResults: 
results. The mean age was 39 years (Range: 16-103 years) and 3,627 (60.7%) 
were female. HIV prevalence was 9.7% and about 40% of the population were
pre-hypertensive or hypertensive. The mean serum creatinine level was 0.75
mg/dl (95% CI 0.74–0.75), and the average eGFR was 109.3 ml/min/1.73 m
(95% CI 108.8–109.9). The overall prevalence of CKD (eGFR <60 ml/min/1.73
m ) was 1.64% (98/5,979) (95% CI 1.34–1.99).  Additionally, 4,792 (80.2%)
were classified as normal (eGFR ≥90 ml/min/1.73 m ), 1,089 (18.2%) as low
(eGFR 60–89 ml/min/1.73 m ), 91 (1.52%) as moderate (eGFR 30–59
ml/min/1.73 m ), 4 (0.07%) as severe (eGFR 15-29 ml/min/1.73 m ), and 3
(0.05%) classified as having kidney failure (eGFR <15 ml/min/1.73 m ).  When
age-standardised to the WHO Standard Population the prevalence of CKD was
1.79%. Age above 35 years (OR 78.3, 95% CI 32.3–189), and the presence of
hypertension (OR 2.98, 95% CI 1.47-6.02) and anaemia (OR 2.47, 95% CI
1.37-4.42) were associated with CKD.
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 1.37-4.42) were associated with CKD.
We found a substantial prevalence of CKD in rural Uganda,Conclusion:  
strongly associated with high blood pressure and anaemia.
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Introduction
Chronic kidney disease (CKD) is an under-recognized non-
communicable disease, associated with a high morbidity and 
mortality. It is estimated that one in ten people are living with 
kidney disease worldwide and the prevalence may be higher in 
low-income countries such as Uganda1,2. However, as shown 
in a recent systematic review the quality of data is often poor, 
frequently using convenience samples in high-risk populations3. 
Furthermore, only 2% of the studies included in this review used 
the CKD-EPI formula for calculation of estimated glomerular 
filtration rate (eGFR) which, based on limited data, has been 
found to be the best estimate of population CKD prevalence3,4. 
Community-based studies of the prevalence of CKD (defined as 
an eGFR<60 ml/minute/1.73m2) have shown marked variation 
in results. Among people living with HIV/AIDS, estimates 
range from 0.7% in Rakai, Central Uganda, 14.4% in Gulu, 
Northern Uganda, 26.5% in Zambia to 41.3% in Tanzania5–8. 
Among HIV-negative populations, estimates range from 2.5% 
in Wakiso, Central Uganda to 26.5% in Tanzania8,9. Hospital- 
based studies from a National Referral Hospital in Uganda 
show that most patients with kidney disease are young and have 
advanced disease by the time of presentation10. Thus, in sub- 
Saharan Africa estimates of kidney disease prevalence vary 
widely depending on the methods used to determine CKD and 
the population studied, in particular the age distribution8,11–19.
Globally, among the known key risk factors for CKD are 
diabetes mellitus, hypertension and infections such as HIV. 
Hypertension and HIV are important problems in Uganda with 
hypertension prevalence estimated to be 26.4%20 and rising 
among those with HIV-infection21. However, the prevalence of 
diabetes mellitus is low compared to high-income countries at 
2%22. Moreover, some studies have also highlighted differences 
in CKD prevalence between urban and rural Africa. A study 
from Cameroon found the overall prevalence of CKD to be 
13.2%: 14.1% and 10.9% among rural and urban dwellers, 
respectively23. Late diagnosis, along with limited heath care 
leading to poor control of hypertension and diabetes may be 
possible drivers of a higher prevalence in rural populations.
Therefore, we aimed to determine the prevalence and associa-
tions of CKD among a representative rural population in Uganda, 
within an existing population cohort using high quality sampling 
methods.
Methods
Study design and setting
The General Population Cohort (GPC) was originally established 
in 1989, by the United Kingdom Medical Research Council 
and the Uganda Virus Research Institute, in Kalungu District, 
South-western Uganda24. The cohort was initially established 
to examine prevalence, incidence, risk factors and trends of 
infection with HIV in a rural African population. More recently, 
research activity has broadened to include the epidemiology 
and genetics of other communicable and of non-communicable 
diseases, including cancer, cardiovascular disease and diabetes24,25. 
In brief, the GPC is a community-based open cohort study of 
residents of 25 neighbouring villages within one-half of a 
sub-county, lying about 40 km from Lake Victoria. The population 
is scattered across the countryside in villages defined by admin-
istrative boundaries, with a few concentrated in small trading 
centres. The population under survey includes approximately 
22,000 people, less than half of whom are more than 13 years of 
age. The cohort is dynamic with new births, deaths and migra-
tion reported at each round of follow-up. Data are collected 
through an annual census, an annual questionnaire and sero-
logical survey from 1989–2011 and a biennial questionnaire and 
serological survey thereafter. Details of sexual behaviour, 
medical, sociodemographic and geographic factors are recorded. 
Blood specimens are obtained at each biennial survey. Serum 
is tested for HIV-1 and the remainder is stored at -80°C. Since 
1989, the seroprevalence of HIV has remained relatively 
stable in this population, with about 8% of participants infected; in 
recent years, prevalence has risen slightly, with the roll out of 
antiretroviral therapy and consequent improvements in survival.
Variables used for analysis were extracted from two separate 
survey rounds of the GPC (2011–2012 and 2014–2015), and 
participants’ information gathered from questionnaire and 
laboratory data of the survey rounds were linked by unique 
identifiers. For adults (18+ years for males and 16+ years for 
females), variables used to develop a socioeconomic score 
(SES), smoking status, alcohol consumption, fruit and vegetable 
intake and results of Hepatitis B and C tests were derived 
from the 2011–2012 survey round. Variables associated with 
participant’s eGFR, age, maximum education level, current 
marital status, history of stroke, body mass index (BMI) and HIV 
status were based on the 2014–2015 survey round.
Data collection
Data collected from the GPC questionnaire regarding sexual 
behaviour and lifestyle factors were self-reported (Supplementary 
File 1). Anthropometric measurements and blood tests were 
performed by trained interviewers/nurses using calibrated 
instruments and following standard operating procedures. We 
adapted the World Health Organization (WHO) STEP-wise 
approach to surveillance questionnaire to obtain socio- 
demographic characteristics, lifestyle (diet, tobacco, and alcohol 
consumption), medical history and biophysical measurements. 
Blood pressure was measured using a digital sphygmomanom-
eter (Omron M4-1). The participant had to be in a sitting position 
and the mean of the second and third readings taken at 5-minute 
intervals was used for analysis. Body weight was measured 
using the Seca 761 mechanical scales and body height was 
measured using a stadiometer to the nearest 1 kg and 0.1 cm, 
respectively. Both scales were calibrated according to manufac-
turer guidelines weekly.
Laboratory tests
Blood tests for haemoglobin, HIV screening, HbA1c, hepatitis B 
and C viruses, as well as the creatinine level were performed. 
Venous blood was tested for haemoglobin level using CT -5 
Coulter Ac.T 5diff AL (Autoloader) [Beckman Coulter, North 
America]. HIV testing was performed using an approved national 
algorithm26. Hepatitis B surface antigen, Hepatitis C antibody and 
creatinine level were tested using a Cobas e 601 Auto Analyzer 
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(Roche Diagnostics, North America). Creatinine was meas-
ured using the enzymatic method traceable to an isotope dilution 
mass spectrometry method27. The MRC/UVRI Entebbe laborato-
ries currently have laboratory accreditation through ISO 15189 
of the Kenya Accreditation Service, and are enrolled in external 
quality control programs for South Africa, America, Australia 
and the United Kingdom.
Definitions and classification
Each participant’s SES was derived from conducting principal 
component analysis (PCA) using variables relating to household 
infrastructure and property ownership. Urbanicity score 
used in this study was derived from a previous study using 
information from the Round 22 survey28. BMI was classified 
according to WHO categories (weight/height2: kg/m2): underweight 
(<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight 
(25.0-29.9 kg/m2) and obese (>30.0 kg/m2). Blood pressure (BP) 
classification was derived from the National Institute of Health 
guidelines: Pre-Hypertension was defined as having a systolic 
BP greater than 120mmHg but less than 140 mmHg, and a 
diastolic BP greater than 80 mmHg but less than 90 mmHg. 
Hypertension was defined as having a diastolic BP greater 
than or equal to 90 mmHg, systolic BP greater than or equal to 
140 mmHg or being on treatment for high BP. Anaemia was 
defined as having haemogloblin levels less than 130 g/l in 
men, 120 g/l in non-pregnant women, and 110 g/l in pregnant 
women. Diabetes mellitus was diagnosed by either having HbA1c 
>6.5%, through self-reported measures of being previously 
diagnosed with diabetes, or by current treatment for diabetes.
Diagnosis of CKD
The eGFR was calculated using the CKD-Epi formula, without 
use of the coefficient for African Americans29. We defined CKD 
as having an eGFR <60 ml/min/1.73 m2 based on one estimate 
of eGFR. Impaired renal function was further categorized into 
five categories analogous to CKD stages, according to severity 
based on the National Kidney Foundation guidelines (without 
including proteinuria) as: normal (eGFR ≥90 ml/min/1.73 m2); 
low (eGFR 60-89 ml/min/1.73 m2); moderate (eGFR 30-59 
ml/min/1.73 m2); severe (eGFR 15-29 ml/min/1.73 m2); and 
kidney failure (eGFR <15 ml/min/1.73 m2)30. 
Statistical analysis
Baseline characteristics were tabulated stratified by sex. The 
prevalence of CKD was also age standardised using the WHO 
world population as the reference.
We used logistic regression to estimate odd ratios (OR), along 
with its 95% confidence intervals (95% CIs), to identify potential 
factors independently associated with CKD. A forward step-
wise approach was used in developing our multivariable model 
adjusting for age, sex, and all independent predictors of CKD.
We also conducted a secondary analysis to compare participants 
with GFR<60 ml/min/1.73 m2 to those with normal renal func-
tion excluding individuals with a low kidney disease category 
The population attributable fraction (PAF) of decreased renal 
function was estimated for hypertension, and anaemia using the 
adjusted odds ratios from the final multivariable model.
All statistical analyses were performed using STATA 13 SE 
(Stata Corp, Texas, USA).
Ethical considerations
All study participants gave written informed consent to 
participate in the study. The study was approved by Uganda Virus 
Research Institute Research and Ethics Committee (UVRI-REC) 
and the Uganda National Council for Science and Technology 
(UNCST).
Results
Baseline characteristics of study participants
A total of 6,397 individuals participated in the Round 24 GPC 
survey in 2014-2015 and 5,979 (93.5%) individuals had valid 
creatinine test results. The average age of study participants was 
39 years (range: 16 years to 103 years), consisting of 3,626 
(60.7%) females. The majority of patients had primary-level 
education (60.4%). HIV prevalence was 9.7% (males: 8.4%, 
females: 10.5%) within this study population, and about 40% 
of the population was classified as pre-hypertensive. The mean 
serum creatinine level of the study population was 66.3 mmol/l 
(95% CI 65.4–66.3), and using the CKD-EPI equation, the 
average eGFR was 109.3 ml/min/1.73 m2 (95% CI 108.8–109.9) 
(Table 1).
Prevalence of impaired renal function
The overall prevalence of CKD was 1.6% (95% CI 1.34–1.99). 
Of the respondents, 4,792 (80.2%) were classified as normal, 
1,089 (18.2%) as low, 91 (1.5%) as moderate, 4 (0.1%) as 
severe, and 3 (0.1%) classified as having kidney failure 
(Figure 1, Table 2). The prevalence of decreased renal function 
among those over the age of 16, age-standardised to the WHO 
population, was 1.8%.
Factors associated with kidney disease
Among the socio-demographic variables, age above 35 years 
was independently associated with CKD (OR 78.28; 95% CI 
32.28–189.26). CKD increased with increasing age: for those 
35–44 years (OR 0.53; 95% CI 0.05-5.14) compared to above 
75 years (OR 29.68; 95% CI 7.99-110.19). Low education 
level was associated with increased risk of CKD (OR 2.00; 
95% CI 1.10-3.62). There was no association between CKD 
and behavioral risk factors or anthropometric measurements 
(Supplementary Table 1).
Hypertension (OR 2.98; 95% CI 1.47-6.02) and anaemia 
(OR 2.47; 95% CI 1.37-4.42) were associated with CKD 
(Table 3).
Comparison of patients with eGFR of <90 mls/min/1.73m2 and 
those with normal kidney function showed that being female 
(OR 1.56, 95% CI 1.27-1.93); age >35 years (OR 4.35, 95% 
CI 3.00-6.31); urbanicity (OR 1.41 95% CI 1.09-1.82); being 
overweight (OR 1.47, 95% CI 1.13-1.91); having hypertension 
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Table 1. Characteristics of participants with creatinine results 
from Survey round 24 among a general population cohort in 
rural Uganda (N=5,979).
Variable Male, n (%) Female,  
n (%)
Total, n (%)
Age Group
<35 1,033 (43.90) 1,703 (46.97) 2,736 (45.77)
35–44 460 (19.55) 721 (19.88) 1,181 (19.74)
45–54 378 (16.02) 507 (13.98) 884 (14.79) 
55–64 244 (10.37) 336 (9.27) 580 (9.70) 
65–74 138 (5.86) 231 (6.37) 369 (6.17) 
75+ 101 (4.29) 128 (3.53) 229 (3.83) 
Max Education 
None 137 (5.82) 394 (10.87) 531 (8.88) 
Primary 1,488 (63.24) 2,122 (58.52) 3,610 (60.38) 
Secondary 570 (24.21) 946 (26.09) 1,516 (25.35) 
Higher Level 158 (6.71) 164 (4.52) 322 (5.38) 
Currently Married**
No 357 (20.62) 1,075 (36.68) 1,432 (30.72) 
Yes 1,373 (79.36) 1,856 (63.32) 3,229 (69.28) 
Urbanicity*1 
Quartile 1 513 (28.71) 756 (26.31) 1,259 (27.24) 
Quartile 2 468 (26.19) 733 (25.86) 1,201 (25.98) 
Quartile 3 436 (24.40) 697 (24.59) 1,133 (24.51) 
Quartile 4 370 (20.71) 659 (23.25) 1,029 (22.26) 
SES*2 
Lower 565 (35.76) 819 (32.79) 1,384 (33.94) 
Middle 521 (33.04) 833 (33.35) 1,354 (33.23) 
Upper 493 (31.20) 846 (33.87) 1,339 (32.83) 
BMI3** 
Normal weight 1,786 (76.47) 2,290 (65.84) 4,076 (70.11) 
Underweight 407 (17.42) 302 (8.68) 709 (12.19) 
Overweight 122 (5.22) 648 (18.63) 770 (13.24) 
Obese 21 (0.90) 238 (6.84) 259 (4.45) 
Blood Pressure*4 
Normal 668 (40.44) 1,235 (48.82) 1,903 (45.51) 
Pre-Hypertension 719 (43.52) 944 (37.28) 1,663 (39.75) 
Hypertension 265 (16.04) 352 (13.90) 617 (14.75) 
Variable Male, n (%) Female,  
n (%)
Total, n (%)
HIV Status** 
Negative 2,150 (91.57) 3,242 (89.51) 5,392 (90.32) 
Positive 198 (8.43) 380 (10.49) 578 (9.68) 
Hepatitis B* 
Negative 1,588 (96.48) 2,479 (98.10) 4,067 (97.46) 
Positive 58 (3.52) 48 (1.90) 106 (2.54) 
Hepatitis C* 
Negative 1,582 (96.17) 2,439 (96.52) 4,021 (96.38) 
Positive 63 (3.83) 88 (3.48) 151 (3.62) 
Anaemia*5 
Negative 1,078 (86.87) 1,583 (83.40) 2,661 (84.77) 
Positive 163 (13.13) 315 (16.60) 478 (15.23) 
Diabetes*6 
No 1,603 (97.74) 2,467 (97.94) 4,070 (97.53) 
Yes 37 (2.26) 52 (2.06) 89 (2.14) 
Current smoking status* 
Not current smoker 1,301 (78.80) 2,478 (97.87) 3,779 (90.34) 
Non-daily smoker 83 (5.03) 17 (0.67) 100 (2.39) 
Daily smoker 267 (16.17) 37 (1.46) 304 (7.27) 
Alcohol consumption* 
Never drinkers 831 (54.64) 1,589 (69.27) 2,420 (63.43) 
No alcohol in past 
30 days 
90 (5.92) 250 (10.90) 340 (8.91) 
Alcohol in past 30 
days 
600 (39.45) 455 (19.83) 1,055 (27.65) 
*Variables from a previous round (R22) of the GPC where total number of 
participants may vary: Urbanicity (n=4,622), SES (n=4,077), Blood Pressure 
(BP) (n=4,184), Hepatitis B (n=4,173), Hepatitis C (n=4,172), smoking 
status (n=4,183), alcohol consumption in the last 30 days (n=3,815), and 
anaemia (n=3,139). 1Urbanicity score derived from Riha et al. (2014). 
2Socio-economic Score (SES) derived from conducting Principle Component 
Analysis (PCA) on a statistical software using variables relating to household 
infrastructure and property ownership 3Body Mass Index (BMI) Classification 
according to WHO (weight/height2: kg/m2): Underweight (<18.5 kg/m2), 
Normal weight (18.5–24.99 kg/m2), Overweight (25.0–29.99 kg/m2), Obese 
(>30.0 kg/m2). 4BP classification derived from the National Institute of 
Health guidelines: Pre-Hypertension was defined as having a systolic BP 
>120mmHg but <140 mmHg, and a diastolic BP >80 mmHg but <90 mmHg. 
Hypertension was defined as having a systolic BP ≥90mmHg, diastolic BP 
≥140mmHg. 5Anaemia was defined as having haemogloblin levels less than 
130 g/L in men, 120 g/L in non-pregnant women, and 110 g/L in pregnant 
women. Only 2,064 individuals had anaemia results from the R24 of the GPC
6Diabetes was defined as having HbA1C >6.5%, or being previously 
diagnosed with diabetes, or are currently on treatment for diabetes. 
**Variables in R24 with missing individuals: Currently Married (n=4,661), BMI 
(n=5,814), HIV (n=5,970)
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Figure 1. Prevalence of estimated glomerular filtration rate <60 ml/min/1.73 m2 by age group among a rural Ugandan cohort.
Table 2. Mean serum creatinine and estimated glomerular filtration 
rate (eGFR), along with prevalence of chronic kidney disease in 
the general population cohort.
Variables Mean (95% CI)
Measurements
Serum creatinine (mg/dl) 0.75 (0.74–0.75)
eGFR (ml/min/1.73m2)
   CKD-EPI equation*1 109.3 (108.8–109.9)
   MDRD equation* 106.2 (105.4–107.1)
Individuals n(%)
Chronic kidney disease category
Normal (eGFR ≥90 ml/min per 1.73 m2) 4,792 (80.15)
Low (eGFR 60–89 ml/min per 1.73 m2) 1,089 (18.21)
Moderate (eGFR 30–59 ml/min per 1.73 m2) 91 (1.52)
Severe (eGFR 15–29 ml/min per 1.73 m2) 4 (0.07)
Kidney Failure (eGFR <15 ml/min per 1.73 m2) 3 (0.05)
*The CKD-EPI eGFR calculations were used as the primary outcomes in this 
study; the MDRD equation was used to contrast the difference between the two 
equations. 1The coefficient for black race was omitted while using this equation.
(OR 1.60, 95 % CI 1.22-2.11) and HIV-positive status (OR 1.55, 
95% CI 1.13-2.04) were associated with impaired kidney function 
(Supplementary Table 2 and Supplementary Table 3).
Comparison of participants with CKD and those with 
eGFR >90 ml/min/1.73m2 revealed that age >35 years, hypertension 
and anaemia were associated with CKD (Supplementary Table 4).
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Table 3. Final multivariable model of factors 
independently associated with estimated 
glomerular filtration rate <60 ml/min per 1.73m2.
Variable Adjusted OR (95% CI)1
Sex P=0.56
Male Reference 
Female 1.19 (0.64-2.24)
Age Group P<0.001
<35 Reference 
35–44 0.53 (0.05-5.14)
45–54 3.49 (0.86-14.09)
55–64 5.73 (1.47-22.25)
65–74 12.24 (3.27-45.82)
75 + 29.68 (7.99-110.19)
Blood Pressure*2 P=0.05
Normal Reference 
Pre-Hypertension 1.92 (0.81-4.57)
Hypertension 2.86 (1.15-7.08)
Anaemia3 P=0.02
Negative Reference 
Positive 2.14 (1.12-4.09)
*Variables from a previous round (R22) of the GPC 
where total number of participants may vary: Blood 
Pressure (n=3,039).
1Multivariable model adjusted for age, sex and all 
independent predictors of CKD. OR, odds ratio; 95% CI, 
95% confidence interval. 2Blood pressure classification 
derived from the National Institute of Health guidelines: 
Pre-Hypertension was defined as having a systolic 
blood pressure greater than 120 mmHg but less than 
140 mmHg, and a diastolic blood pressure greater 
than 80 mmHg but less than 90 mmHg. Hypertension 
was defined as having a systolic blood pressure (BP) 
greater than or equal to 90mmHg, diastolic BP greater 
than or equal to 140mmHg. 
3Anaemia was defined as having haemoglobin levels 
less than 130 g/l in men, 120 g/L in non-pregnant 
women, and 110 g/l in pregnant women. Only 2,064 
individuals had anaemia results from the R24 of the GPC
The adjusted population attributable fraction of decreased renal 
function attributable to hypertension and anaemia was 26.4% and 
12.8%, respectively.
Discussion
We found a prevalence of CKD of 1.64% in this predominantly 
young rural community of Uganda with more than one-fifth of the 
study participants having impaired renal function. The prevalence 
of CKD rose with increasing age and was rare below the age of 
35 years. CKD was more prevalent in females and those with low 
education status and, as expected, was associated with high blood 
pressure and anaemia
Comparing different prevalence estimates of CKD from studies 
across sub-Saharan Africa is challenging due to vastly different 
age structures. In a meta-analysis of CKD in sub-Saharan Africa 
by Stanifer et al.3. the overall prevalence was 13.9% but the 
majority of the studies were conducted among patients with 
known risk factors for CKD such as diabetes mellitus, HIV 
infection and hypertension. Furthermore, only 2% of the included 
studies used the CKD-EPI formula for calculation of eGFR 
although, based on limited data, it has been found to be the best 
estimate of population CKD prevalence3,4. It is thus apparent 
that the prevalence of CKD varies widely between regions, the 
definition used and the prevalence of risk factors among the study 
population.
We found that age above 35 years, low education status, hyper-
tension and anaemia were associated with CKD. Age is known 
to be strongly associated with eGFR3,23,29. Hypertension is both a 
cause and a consequence of kidney disease, and in this 
cross-sectional survey it was not possible to tell whether the 
participants had hypertension as a cause or consequence of the 
kidney disease. However there has been a rise in reported levels 
of hypertension in Uganda, from 13.7%31 in 1969 to 26.4% in 
201520. Anaemia is also often a consequence of kidney disease, 
or may be due to shared risk-factors such as other chronic 
diseases. We found that anaemia was associated with kidney 
disease, even for patients with eGFR <90 ml/min/1.73m2, a level 
of kidney function at which a direct causal effect would not be 
anticipated. Factors which have been traditionally associated 
with kidney disease in high-income countries such as smoking, 
alcohol intake and obesity were not associated with CKD in this 
population. This may be because of the low prevalence of these 
factors in the community, or may suggest that the risk factors 
for CKD are different in this region. Indeed, other researchers 
have found that the majority of kidney disease in SSA is not 
explained by traditional risk factors32.
Study strengths and limitations
This was a large community-based study conducted within a 
well-characterized population cohort. We used the CKD-Epi 
formula to determine eGFR, which is thought to be the best 
estimate of true GFR in sub-Saharan Africa. However, marked 
uncertainty remains about how best to estimate true GFR in black 
Africans. We measured a wide range of social and anthropomet-
ric factors, chronic diseases and biochemical measurements in a 
structured and validated manner. In addition, our prevalence 
estimates have been standardized to the WHO population to 
enable comparability with other studies across the world.
However, there were limitations, including lack of screening for 
urine abnormalities (proteinuria and hematuria) which could 
have led us to underestimate the prevalence of CKD. Newer 
classifications of CKD require measurement of proteinuria to 
define CKD4. We only measured creatinine on one occasion; two 
screenings are required for the formal definition of CKD.
Implications of the study
Interventions for end-stage renal disease are currently 
limited for most countries in sub-Saharan Africa with very poor 
access to dialysis and kidney transplantation9,33. This study has 
established a significant prevalence of impaired renal function, 
highlighting the need to focus efforts on preventive strategies to 
delay onset and slow progression of renal disease.
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Conclusions
We found that approximately one in five adults in rural Uganda 
had impaired renal function despite a low prevalence of 
diabetes and obesity. Impaired renal function was strongly 
associated with high blood pressure and anaemia. More detailed 
studies are required to further determine specific risk-factors for 
impaired renal function and its progression.
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